Taking people in Belgium2. fázis
[18F]AlF-PSMA-11 PET in advanced thyroid and head and neck carcinoma
Key facts
- Where
- Gent, BelgiumSee the site
- Phase
- 2. fázis
Where in Belgium
- Universitair Ziekenhuis GentGent, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitair Ziekenhuis Gent
- Trial code
- EU 2022-503036-13-00
- Record updated
- 2025. október 7.
- Original description
demonstrate uptake of [¹⁸F]AlF-PSMA-11 in lesions on PET.Read full original descriptionShow less
Prostate-specific membrane antigen in thyroid and head and neck carcinoma: On the utility of [18F]AlF-PSMA-11 PET in advanced disease
demonstrate uptake of [¹⁸F]AlF-PSMA-11 in lesions on PET.
Inclusion: 18 years of age or older; willing and mentally and legally capable of providing written informed consent; have ≥ 1 measurable lesion of interest of ≥ 1.0 cm on medical imaging.
Exclusion: Patients with known hypersensitivity to the [¹⁸F]AlF-PSMA-11 or used excipients; potentially pregnant female patients refusing pregnancy testing at screening; pregnant or breastfeeding female patients.